Physician
Cardiology
Dr. Alan H. Gradman, MD
|
|
Give Review
Alan H. Gradman, MD is an expert in the field of Cardiology. He went to Washington University School of Medicine in St. Louis. He received awards:"Fellow (FACC)". Alan Gradman is also published. He has 90 publications published. The lastest publication: "Long-term efficacy, tolerability, and safety of the combination of enalapril and felodipine ER in the treatment of hypertension. Enalapril-Felodipine ER Factorial Stud...'
Publications
- Efficacy and safety of nebivolol and valsartan as fixed-dose combination in hypertension: a randomised, multicentre study.
- Treating acute heart failure in the elderly: A comparison of three inpatient treatment alternatives in the United States.
- Initial combination therapy reduces the risk of cardiovascular events in hypertensive patients: a matched cohort study.
- Strategies for combination therapy in hypertension.
- Long-Term Safety and Tolerability of the Oral Direct Renin Inhibitor Aliskiren with Optional Add-On Hydrochlorothiazide in Patients with Hypertension: A Randomized, Op...
- Sleep-time blood pressure a validated therapeutic target.
- Renal nerve ablation for resistant hypertension.
- Rationale for triple-combination therapy for management of high blood pressure.
- Combination therapy in hypertension.
- Leadership message. Maintaining core values.
- Aliskiren monotherapy does not cause paradoxical blood pressure rises: meta-analysis of data from 8 clinical trials.
- Direct renin inhibition: an update.
- Hypertension and diastolic heart failure.
- Effect of intracoronary nicardipine on cardiac enzymes after elective percutaneous coronary intervention.
- Evolving understanding of the renin-angiotensin-aldosterone system: pathophysiology and targets for therapeutic intervention.
- Combined renin-angiotensin-aldosterone system inhibition in patients with chronic heart failure secondary to left ventricular systolic dysfunction.
- Vaccination: a novel strategy for inhibiting the renin-angiotensin-aldosterone system.
- Newer combination therapies in the management of hypertension: an update.
- Renin inhibition in hypertension.
- The efficacy of aliskiren, a direct renin inhibitor, in the treatment of hypertension.
- Treating patients for cardiovascular protection: combination therapy to achieve complete renin-angiotensin system blockade.
- New drugs for hypertension: what do they offer?
- From left ventricular hypertrophy to congestive heart failure: management of hypertensive heart disease.
- Aliskiren, a novel orally effective renin inhibitor, provides dose-dependent antihypertensive efficacy and placebo-like tolerability in hypertensive patients.
- Combination angiotensin receptor blocker/hydrochlorothiazide as initial therapy in the treatment of patients with severe hypertension.
- Mechanisms and management of hypertensive heart disease: from left ventricular hypertrophy to heart failure.
- Managing high-risk patients with hypertension: focus on the renin-angiotensin system.
- Reducing radiocontrast use in the cardiac catheterization laboratory--a behavioral modification approach.
- Evolving strategies for the use of combination therapy in hypertension.
- A multicenter, randomized, double-blind, placebo-controlled, 8-week trial of the efficacy and tolerability of once-daily losartan 100 mg/hydrochlorothiazide 25 mg and ...
- Left anterior descending coronary artery to right ventricular fistula complicating coronary stenting.
- Effect of nesiritide on renal function in patients admitted for decompensated heart failure.
- Effects of losartan and captopril on left ventricular volumes in elderly patients with heart failure: results of the ELITE ventricular function substudy.
- Effects of once-daily benazepril therapy on exercise tolerance and manifestations of chronic congestive heart failure. The Benazepril Heart Failure Study Group.
- Combined alpha/beta-blockade versus beta 1-selective blockade in essential hypertension in black and white patients.
- Predictors of total mortality and sudden death in mild to moderate heart failure. Captopril-Digoxin Study Group.
- The role of denial in recovery from coronary heart disease.
- Antihypertensive efficacy and safety of losartan alone and in combination with hydrochlorothiazide in adult African Americans with mild to moderate hypertension.
- Antihypertensive efficacy of candesartan in comparison to losartan: the CLAIM study.
- Underutilization and clinical benefits of angiotensin-converting enzyme inhibitors in patients with asymptomatic left ventricular dysfunction.
- Cardiac effects of cocaine: a review.
- Situational panic attacks. Behavioral, physiologic, and biochemical characterization.
- Lack of correlation between clinic and 24 hour ambulatory blood pressure in subjects participating in a therapeutic drug trial.
- Lisinopril dose-response relationship in essential hypertension.
- Hemodynamic effects of the vascular selective calcium antagonist felodipine in patients with impaired left ventricular function.
- Supraventricular tachycardia in patients with right hemisphere strokes.
- Hypertension and ischemia: evolving concepts.
- Comparison of sustained-release formulations of nicardipine and verapamil for mild to moderate systemic hypertension.
- Sudden death during ambulatory monitoring. Clinical and electrocardiographic correlations. Report of a case.
- Antiarrhythmic drug effect assessed from ventricular arrhythmia reduction in the ambulatory electrocardiogram and treadmill test: comparison of propranolol, procainami...
- Rapid progression in valvular aortic stenosis.
- Suppression of premature ventricular contractions by acebutolol.
- Long-term benefits of angiotensin II blockade: is the consensus changing?
- Effects of candesartan cilexetil in patients with severe systemic hypertension. Candesartan Cilexetil Study Investigators.
- Comparison of two strategies for intensifying antihypertensive treatment: low-dose combination (enalapril + felodipine ER) versus increased dose of monotherapy (enalap...
- Assessment of once-daily eprosartan, an angiotensin II antagonist, in patients with systemic hypertension. Eprosartan Study Group.
- Long-term efficacy, tolerability, and safety of the combination of enalapril and felodipine ER in the treatment of hypertension. Enalapril-Felodipine ER Factorial Stud...
- A randomized, double-blind, placebo-controlled, parallel-group, multicenter trial of four doses of tasosartan in patients with essential hypertension. Tasosartan Inves...
- Combined enalapril and felodipine extended release (ER) for systemic hypertension. Enalapril-Felodipine ER Factorial Study Group.
- Double-blind evaluation of the dose-response relationship of amlodipine in essential hypertension.
- Treatment of hypertension with felodipine in patients with concomitant diseases.
- Monitoring blood pressure in ambulatory patients.
- Hypertension in the elderly: age- and disease-related complications and therapeutic implications.
- Predictors of mortality in patients with heart failure.
- Disappearing cardiac masses--the importance of intraoperative transesophageal echocardiography.
- A randomized, placebo-controlled, double-blind, parallel study of various doses of losartan potassium compared with enalapril maleate in patients with essential hypert...
- The evolving role of calcium channel blockers in the treatment of angina pectoris: focus on felodipine.
- Ventricular arrhythmias late after aortic valve replacement and their relation to left ventricular performance.
- Optimal methodology for ambulatory ECG monitoring: continuous or sampled recording?
- Effects of oral digoxin on ventricular ectopy and its relation to left ventricular function.
- High dose propranolol in the treatment of angina pectoris: relationship of dose to blood levels and hemodynamic consequences.
- Variability of repetitive arrhythmia formation in patients with chronic ventricular arrhythmia.
- Techniques of blood pressure monitoring during exercise.
- Ambulatory electrocardiographic correlates of ventricular inducibility during programmed electrical stimulation.
- AT(1)-receptor blockers: differences that matter.
- Allergic angina and allergic myocardial infarction: a new twist on an old syndrome.
- Hepatitis C virus-associated pericardial effusion and tamponade in a liver transplant recipient.
- The no-reflow phenomenon: epidemiology, pathophysiology, and therapeutic approach.
- Cardiovascular surgical outcomes in patients with the antiphospholipid syndrome--a case-series.
- Plasma renin and the antihypertensive effect of the orally active renin inhibitor aliskiren in clinical hypertension.
- Evolving clinical application of cardiac MRI.
- New therapeutic perspectives with clevidipine: an ultra-short-acting intravenous Ca2+ channel blocker.
- Current concepts: renin inhibition in the treatment of hypertension.
- Adding nebivolol to ongoing antihypertensive therapy improves blood pressure and response rates in patients with uncontrolled stage I-II hypertension.
- Managing cardiovascular and renal risk: the potential of direct renin inhibition.
- Role of angiotensin II type 1 receptor antagonists in the treatment of hypertension in patients aged >or=65 years.
- Efficacy, safety and tolerability of aliskiren, a direct renin inhibitor, in women with hypertension: a pooled analysis of eight studies.
- Difficult-to-Treat or Resistant Hypertension: Etiology, Pathophysiology, and Innovative Therapies.
- Comparative effects of candesartan cilexetil and losartan in patients with systemic hypertension. Candesartan Versus Losartan Efficacy Comparison (CANDLE) Study Group.
Schools
Washington Center School of Medicine
Doctors Specialties
- Cardiology
Accepted Insurances
Awards
- Fellow (FACC)
Education
-
Washington University - Barnes-Jewish Hospital -
Washington University School of Medicine in St. Louis
Helpful Reviews
Similar Doctors
|
|
Dr. Rene Alvarez, MD |
|
|
Dr. Sobhan Kodali, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. William P. Follansbee, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Prem Soman, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Orestis Pappas, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Anson J. Smith, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Brian L. Henry, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sudhakar P. Reddy, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Christopher M. Wentz, MD
This Doctor is OpenDoctor Recommended.
|